EPISODE · Jun 12, 2026 · 5 MIN
新型P-CABs抑酸剂：迈向超越抑酸的疾病特异性应用
from 消化肝病前沿资讯
本期播客围绕新型胃酸抑制药P-CABs展开讨论，打破“药效越强越好”的固有认知，结合胃食管反流病、幽门螺杆菌根除等不同消化疾病的治疗效果，分析其临床优势与局限，同时提醒关注长期用药的安全性问题，倡导基于循证医学的个体化用药，纠正盲目追捧新药的错误观念。00:06P-CABs研发思路存偏差00:34强效抑酸未必疗效更优01:23P-CABs优势因病而异02:02多病种疗效与用药误区02:47长期用药安全性待明确03:30症状与愈合指标非一致04:05个体化用药拒绝盲目追新04:42
Embed this episode
NOW PLAYING
新型P-CABs抑酸剂：迈向超越抑酸的疾病特异性应用
0:00
5:28
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 消化肝病前沿资讯?
This episode is 5 minutes long.
When was this 消化肝病前沿资讯 episode published?
This episode was published on June 12, 2026.
Can I download this 消化肝病前沿资讯 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!